Find therapies in clinical trials near you – page 236

Long-Term Safety Study of GT005 for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration Previously Treated in a Gyroscope Study

Long-Term Safety Study of GT005 for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration Previously Treated in a Gyroscope Study

Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

Study on the Safety and Effects of Tolvaptan for Infants and Young Children with Autosomal Recessive Polycystic Kidney Disease

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Study on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma

Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis

Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

Study of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma

Study of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma

Study of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Study of IO102-IO103 and Pembrolizumab for Patients with Advanced Melanoma

Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Study of Pembrolizumab with Chemotherapy for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Long-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks

Long-term safety study of garadacimab (CSL312) for prevention of hereditary angioedema attacks

Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

Study on the Effectiveness and Safety of L19TNF and Dacarbazine for Patients with Advanced or Metastatic Soft-Tissue Sarcoma After Previous Treatments

Study on the Safety and Effectiveness of AT132 Gene Therapy for Patients with X-Linked Myotubular Myopathy